Hope A. Northrup
Expertise in
10
conditions

Dr. Hope A. Northrup

Medical Genetics | Pediatrics
6410 Fannin St, Ste 500, 
Houston, TX 
Accepting New Patients
Expertise in
10
conditions
6410 Fannin St, Ste 500, 
Houston, TX 

Overview

Hope Northrup is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Houston, Texas.

Dr. Northrup is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Tuberous Sclerosis, Cortical Dysplasia, Epilepsy in Children, and Phenylketonuria (PKU).

She is actively involved in clinical research, co-authoring 135 peer reviewed articles and participating in 7 clinical trials. Dr. Northrup is currently accepting new patients.

Specialties

Medical Genetics
Pediatrics

Licenses

Pediatrics in TX

Fellowships

Baylor College of Medicine 1989

Hospital Affiliations

Children's Memorial Hermann Hospital
Memorial Hermann Texas Medical Center

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
Sutter Health
  • HMO
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

6410 Fannin St, Ste 500, Houston, TX 77030

Additional Areas of Focus

Dr. Northrup has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Tuberous Sclerosis

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)
Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)
Enrollment Status: Active_not_recruiting
Publish Date: August 06, 2026
A Phase 3 Open-Label Study of PTC923 (Sepiapterin) in Phenylketonuria
A Phase 3 Open-Label Study of PTC923 (Sepiapterin) in Phenylketonuria
Enrollment Status: Active_not_recruiting
Publish Date: June 23, 2026
Intervention Type: Drug
Study Drug: PTC923
Study Phase: Phase 3
A Phase 1/2 Open-Label, Dose Escalation Study to Determine the Safety and Efficacy of BMN 307, an Adeno-Associated Virus Vector-Mediated Gene Transfer of Human Phenylalanine Hydroxylase in Subjects with Phenylketonuria
A Phase 1/2 Open-Label, Dose Escalation Study to Determine the Safety and Efficacy of BMN 307, an Adeno-Associated Virus Vector-Mediated Gene Transfer of Human Phenylalanine Hydroxylase in Subjects with Phenylketonuria
Enrollment Status: Active_not_recruiting
Publish Date: December 12, 2024
Intervention Type: Drug
Study Drug: BMN 307
Study Phase: Phase 1/Phase 2
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
Enrollment Status: Completed
Publish Date: May 16, 2024
Intervention Type: Drug
Study Drug: TAVT-18 (sirolimus)
Study Phase: Phase 1/Phase 2
A Phase 3 Study of PTC923 in Subjects With Phenylketonuria
A Phase 3 Study of PTC923 in Subjects With Phenylketonuria
Enrollment Status: Completed
Publish Date: January 10, 2024
Intervention Type: Drug
Study Drug: PTC923
Study Phase: Phase 3
An Open-label Study of the Efficacy and Safety of SYNB1618 and SYNB1934 in Patients With Phenylketonuria (SynPheny-1)
An Open-label Study of the Efficacy and Safety of SYNB1618 and SYNB1934 in Patients With Phenylketonuria (SynPheny-1)
Enrollment Status: Completed
Publish Date: October 17, 2022
Intervention Type: Drug
Study Drug: SYNB1618
Study Phase: Phase 2
Longitudinal Study to Identify Early Biomarkers of Autism Spectrum Disorder (ASD) in Infants With Tuberous Sclerosis Complex (TSC)
Longitudinal Study to Identify Early Biomarkers of Autism Spectrum Disorder (ASD) in Infants With Tuberous Sclerosis Complex (TSC)
Enrollment Status: Completed
Publish Date: February 04, 2021
View 6 Less Clinical Trials

135 Total Publications

Electroencephalographic Transient Beta Event Rates in Autism and Related Neurogenetic Conditions.
Electroencephalographic Transient Beta Event Rates in Autism and Related Neurogenetic Conditions.
Journal: medRxiv : the preprint server for health sciences
Published: August 20, 2026
Similar Doctors
Expertise in
22
conditions
Dr. Fernando Scaglia
Medical Genetics | Pediatrics
Expertise in
22
conditions
Dr. Fernando Scaglia
Medical Genetics | Pediatrics
Referral may be required

Baylor College Of Medicine

7200 Cambridge St, Fl 10, 
Houston, TX 
 (1.0 miles away)
713-798-1000
Languages Spoken:
English, Portuguese
See accepted insurances
Accepting New Patients
Offers Telehealth

Fernando Scaglia is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Houston, Texas. Dr. Scaglia is highly rated in 22 conditions, according to our data. His clinical expertise encompasses MELAS Syndrome, Hypotonia, Primary Carnitine Deficiency, Leigh Syndrome, and Gastrostomy. Dr. Scaglia is currently accepting new patients.

Expertise in
9
conditions
Dr. Lorraine Potocki
Medical Genetics | Pediatrics
Expertise in
9
conditions
Dr. Lorraine Potocki
Medical Genetics | Pediatrics
Referral may be required

Texas Childrens Physician Group

6651 Main St, 
Houston, TX 
 (0.5 miles away)
832-826-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Lorraine Potocki is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Houston, Texas. Dr. Potocki is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Potocki-Lupski Syndrome, Smith-Magenis Syndrome, Hypotonia, and Trisomy 17 Mosaicism. Dr. Potocki is currently accepting new patients.

Expertise in
39
conditions
Dr. Nicola Brunetti-Pierri
Pediatrics | Medical Genetics
Expertise in
39
conditions
Dr. Nicola Brunetti-Pierri
Pediatrics | Medical Genetics
Referral may be required
2 Greenway Plz, Suite 900, 
Houston, TX 
 (2.4 miles away)
713-798-1750
Languages Spoken:
English

Nicola Brunetti-Pierri is a Pediatrics specialist and a Medical Genetics provider practicing medicine in Houston, Texas. Dr. Brunetti-Pierri is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Crigler-Najjar Syndrome, Rotor Syndrome, Pyruvate Decarboxylase Deficiency, and Argininosuccinic Aciduria.

Frequently Asked Questions about Dr. Hope A. Northrup

How do I make an appointment with Dr. Hope A. Northrup?

You can book an appointment with Dr. Hope A. Northrup by calling their office at 713-500-5760. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Hope A. Northrup a top-rated expert for Tuberous Sclerosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Hope A. Northrup is classified as an Elite expert for Tuberous Sclerosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Hope A. Northrup specialize in?

While Dr. Hope A. Northrup is a Medical Genetics, they have specific expertise in Tuberous Sclerosis, Cortical Dysplasia, and Epilepsy in Children. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Medical Genetics.

Does Dr. Hope A. Northrup participate in research or clinical trials?

Yes. Dr. Hope A. Northrup has published 135 articles and abstracts on conditions like Tuberous Sclerosis. You can view a list of Dr. Hope A. Northrup's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Hope A. Northrup accept my insurance?

Dr. Hope A. Northrup accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 713-500-5760 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Northrup's expertise for a condition
ConditionClose
View All 137 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile